bullish
IPCA: Annual Report FY18: Normal Service to Resume
455 Views01 Aug 2018 17:17
Ipca Laboratories (IPCA IN)'s FY18 revenue grew ~2.5% YoY to Rs. 32,587 mn. EBITDA stood at Rs. 4,812 mn (6.3% YoY growth), with the margins of...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 10-minute read)
Discussions
(Paid Plans Only)
Trivikram Consultants
Picking Long Term Multi-bagger stocks
Price Chart(Sign Up to Access)
- IPCA Laboratories- 2QFY19 Results – Growing While Awaiting USFDA Approvals29 Nov 2018
- IPCA Labs: 1QFY19 Result - International Sales Decline but EBITDA Margins Improve21 Aug 2018
- IPCA: Annual Report FY18: Normal Service to Resume01 Aug 2018
- IPCA 4QFY18 Results Confirm Recovery Story05 Jun 2018
- IPCA Labs- The Revival Story13 Apr 2018
x